Through comparative analysis between tumor tissues and their paired nonmalignant mucosa, we identified HOXA7 overexpression as a critical prognostic biomarker associated with poor outcomes in ESCC patients. This evidence concerns the gene HOXA7 and esophageal squamous cell carcinoma.